Acorah Software Products - Accounts Production 16.4.675 false true false 22 April 2024 30 April 2025 30 April 2025 15666250 Mr T J Atkinson iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15666250 2024-04-21 15666250 2025-04-30 15666250 2024-04-22 2025-04-30 15666250 frs-core:CurrentFinancialInstruments 2025-04-30 15666250 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2025-04-30 15666250 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2024-04-22 2025-04-30 15666250 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2024-04-21 15666250 frs-core:ShareCapital 2025-04-30 15666250 frs-core:RetainedEarningsAccumulatedLosses 2025-04-30 15666250 frs-bus:PrivateLimitedCompanyLtd 2024-04-22 2025-04-30 15666250 frs-bus:FilletedAccounts 2024-04-22 2025-04-30 15666250 frs-bus:SmallEntities 2024-04-22 2025-04-30 15666250 frs-bus:AuditExempt-NoAccountantsReport 2024-04-22 2025-04-30 15666250 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-22 2025-04-30 15666250 frs-bus:Director1 2024-04-22 2025-04-30 15666250 frs-countries:EnglandWales 2024-04-22 2025-04-30
Registered number: 15666250
Therabiosciences Limited
Unaudited Financial Statements
For the Period 22 April 2024 to 30 April 2025
Elevate Professional Ltd T/A Elevate Accountancy
Unit 5 Marlborough Road
Wrexham Industrial Estate
Wrexham
LL13 9RJ
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 15666250
30 April 2025
Notes £ £
FIXED ASSETS
Intangible Assets 4 7,776
7,776
CURRENT ASSETS
Cash at bank and in hand 160
160
Creditors: Amounts Falling Due Within One Year 5 (39,131 )
NET CURRENT ASSETS (LIABILITIES) (38,971 )
TOTAL ASSETS LESS CURRENT LIABILITIES (31,195 )
NET LIABILITIES (31,195 )
CAPITAL AND RESERVES
Called up share capital 6 1,000
Profit and Loss Account (32,195 )
SHAREHOLDERS' FUNDS (31,195)
For the period ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr T J Atkinson
Director
31/07/2025
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Therabiosciences Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15666250 . The registered office is 167-169 Great Portland Street, 5th Floor, London, W1W 5PF.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Intangible Fixed Assets and Amortisation - Intellectual Property
Intellectual property assets are patent and intellectual property costs. It is amortised to the profit and loss account over its estimated economic life of ten years.
3. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
4. Intangible Assets
Intellectual Property
£
Cost
As at 22 April 2024 -
Additions 8,640
As at 30 April 2025 8,640
Amortisation
As at 22 April 2024 -
Provided during the period 864
As at 30 April 2025 864
Net Book Value
As at 30 April 2025 7,776
As at 22 April 2024 -
5. Creditors: Amounts Falling Due Within One Year
30 April 2025
£
Amounts owed to participating interests 8,800
Other creditors 30,331
39,131
6. Share Capital
30 April 2025
£
Allotted, Called up and fully paid 1,000
Page 2